Tubeimoside-1 suppresses breast cancer metastasis through downregulation of CXCR4 chemokine receptor expression
2
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
To examine the effect of TBMS1on breast cancer metastasis, and investigate the potential mechanism by which Tubeimoside- 1 (TBMS1) inhibits the CXCR4 expression in breast cancer cells. The expression of CXCR4 in breast cancer cell lines was determined by immunoblotting and real-time PCR. The effect of TBMS1 on NF-κB binding activity was evaluated by EMSA assay and ChIP analysis. Cell proliferation and invasion were analyzed by MTT assay and transwell invasion assay, respectively. The effect of TBMS1 on breast cancer metastasis was further evaluated in a metastasis model of nude mice. TBMS1 suppressed the expression of CXCR4 through inhibition of NF-κB binding activity. TBMS1 inhibited CXCL12-induced invasion in breast cancer cells, while ectopic expression of CXCR4 abolished the inhibitive activity of TBMS1. TBMS1 suppressed breast cancer metastasis in the metastatic model of nude mice. TBMS1 suppressed the CXCR4-mediated metastasis of breast cancer by inhibiting NF-κB binding activity.
Abstract
To examine the effect of TBMS1on breast cancer metastasis, and investigate the potential mechanism by which Tubeimoside- 1 (TBMS1) inhibits the CXCR4 expression in breast cancer cells. The expression of CXCR4 in breast cancer cell lines was determined by immunoblotting and real-time PCR. The effect of TBMS1 on NF-κB binding activity was evaluated by EMSA assay and ChIP analysis. Cell proliferation and invasion were analyzed by MTT assay and transwell invasion assay, respectively. The effect of TBMS1 on breast cancer metastasis was further evaluated in a metastasis model of nude mice. TBMS1 suppressed the expression of CXCR4 through inhibition of NF-κB binding activity. TBMS1 inhibited CXCL12-induced invasion in breast cancer cells, while ectopic expression of CXCR4 abolished the inhibitive activity of TBMS1. TBMS1 suppressed breast cancer metastasis in the metastatic model of nude mice. TBMS1 suppressed the CXCR4-mediated metastasis of breast cancer by inhibiting NF-κB binding activity.
참고문헌 (24)
- Geiger TR, "Metastasis mechanisms", Biochim Biophys Acta, 1796, pp.293~308 (2009)
- Raman D, "Role of chemokines in tumor growth", Cancer Lett, 256, pp.137~165 (2007)
- Ben-Baruch A, "Organ selectivity in metastasis:regulation by chemokines and their receptors", Clin Exp Metastasis, 25, pp.345~356 (2008)
- Franco R, "CXCL12-binding receptors expression in non-small cell lung cancer relates to tumoral microvascular density and CXCR4 positive circulating tumoral cells in lung draining venous blood", Eur J Cardiothorac Surg, 41, pp.368~375 (2012)
- Zeelenberg IS, "The chemokine receptor CXCR4 is required for outgrowth of colon carcinoma micrometastases", Cancer Res, 63, pp.3833~3839 (2003)
- Taichman RS, "Use of the stromal cell-derived factor-1", CXCR4 pathway in prostate cancer metastasis to bone, 2002, pp.62, 1832~1837
- Mori T, "CXCR4 antagonist inhibits stromal cell-derived factor 1-induced migration and invasion of human pancreatic cancer", Mol Cancer Ther, 3, pp.29~37 (2004)
- Richert MM, "Inhibition of CXCR4 by CTCE-9908 inhibits breast cancer metastasis to lung and bone", Oncol Rep, 21, pp.761~767 (2009)
- Yadav VR, "Celastrol suppresses invasion of colon and pancreatic cancer cells through the downregulation of expression of CXCR4chemokine receptor", J Mol Med, 88, pp.1243~1253 (2010)
- Yu TX, "Structure-activity relationship of tubeimosides in anti-inflammatory, antitumor, and antitumor-promoting effects", Acta Pharmacol Sin, 22, pp.463~468 (2001)
- Bian Q, "Tubeimoside-1inhibits the growth and invasion of colorectal cancer cells through the Wnt", beta-catenin signaling pathway, 2015, pp.8, 12517~12524
- Gu Y, "Tubeimoside-1 suppresses tumor angiogenesis by stimulation of proteasomal VEGFR2 and Tie2 degradation in a non-small cell lung cancer xenograft model", Oncotarget, 7, pp.5258~5272 (2015)
- Lin Y, "TBMS1 exerts its cytotoxicity in NCI-H460 lung cancer cells through nucleolar stress-induced p53", MDM2-dependent mechanism, a quantitative proteomics study, 2016, pp.1864, 204~210
- Jia G, "Tubeimoside-1induces glioma apoptosis through regulation of Bax", Bcl-2and the ROS, Caspase-3 pathway, pp.Onco Targets Ther, 2015[DOI]
- Chen WJ, "Tubeimoside-1induces G2", M phase arrest and apoptosis in SKOV-3 cells through increase of intracellular Ca(2)(+)and caspasedependent signaling pathways, 2012, pp.40, 535~543
- Hao W, "Tubeimoside-1(TBMS1)inhibits lung cancer cell growth and induces cells apoptosis through activation of MAPK-JNK pathway", Int J Clin Exp Pathol, 8, pp.12075~12083 (2015)
- Xu C, "CXCR4 in breast cancer: oncogenic role and therapeutic targeting", Drug Des Devel Ther, 9, pp.4953~4964 (2015)
- Kukreja P, "Up-regulation of CXCR4 expression in PC-3 cells by stromal-derived factor-1alpha (CXCL12)increases endothelial adhesion and transendothelial migration: role of MEK", ERK signaling pathway-dependent NF-kappaB activation, 2005, pp.65, 9891~9898
- Nevo I, "The tumor microenvironment: CXCR4 is associated with distinct protein expression patterns in neuroblastoma cells", Immunol Lett, 92, pp.163~169 (2004)
- Duda DG, "CXCL12 (SDF1alpha)-CXCR4", CXCR7pathway inhibition: an emerging sensitizer for anticancer therapies?, 2011, pp.17, 2074~2080
- Staller P, "Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL", Nature, 425, pp.307~311 (2003)
- Richard CL, "Thiazolidinedione drugs down-regulate CXCR4 expression on human colorectal cancer cells in a peroxisome proliferator activated receptor gamma-dependent manner", Int J Oncol, 30, pp.1215~1222 (2007)
- Huang P, "Cytotoxicity of tubeimoside I in human choriocarcinoma JEG-3 cells by induction of cytochrome c release and apoptosis via the mitochondrial-related signaling pathway", Int J Mol Med, 28, pp.579~587 (2011)
- Dalerba P, "Cancer stem cells and tumor metastasis: first steps into uncharted territory", Cell Stem Cell, 1, pp.241~242 (2007)